pharma · Hemophagocytic Syndrome
shifeng Lou
shifeng Lou is a pharma organization headquartered in CN. Primary therapeutic focus areas include Hemophagocytic Syndrome. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this ent
CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Programs
- 1
- Drugs
- 1
- Patents
- 0
Cytoxan
Unknown · small molecule · Hemophagocytic Syndrome
Cytoxan for Hemophagocytic Syndrome is a Unknown program (small_molecule) at shifeng Lou with 1 ClinicalTrials.gov record(s).
Internal code XYNK 04
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- shifeng Lou
- Phase
- Unknown
- Modality
- small_molecule
- Indication
- Hemophagocytic Syndrome
- Status
- active
- Trials
- 1